GlassScriptPhysician profile
Steven W Bigg
NPI 1932166162
$9,394.71
in general payments reported to CMS, 2019-2025
48 companies · $1,539 in 2025
The $1,539 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $911 · 2020: $467 · 2021: $1,395 · 2022: $1,481 · 2023: $1,515 · 2024: $2,087 · 2025: $1,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,647 · Travel and Lodging: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,646.60 |
| Travel and Lodging | $494.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $907.23 | 2019-2025 | |
| Astellas Pharma US INC | $906.27 | 2019-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $837.01 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $593.13 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $570.84 | 2019-2025 | Ams 700, Lumenis Pulse 120h |
| Dendreon Pharmaceuticals LLC | $466.48 | 2021-2025 | Provenge |
| Janssen Biotech, INC. | $428.37 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Myriad Genetic Laboratories, INC. | $365.91 | 2021-2025 | Prolaris |
| Accord Healthcare, INC. | $332.50 | 2023-2024 | |
| Urogen Pharma, INC. | $321.37 | 2022-2025 | |
| Blue Earth Diagnostics | $311.15 | 2021-2023 | |
| Urovant Sciences INC | $258.78 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $229.47 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $224.93 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $210.78 | 2019-2024 | Botox |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $206.79 | 2020-2024 | Xiaflex, Aveed |
| Myovant Sciences INC. | $184.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $163.34 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Progenics Pharmaceuticals, INC. | $148.76 | 2022-2025 | Pylarify |
| Neotract INC. | $144.54 | 2019-2020 | |
| Allergan, INC. | $140.76 | 2019-2021 | |
| Olympus America INC. | $129.39 | 2023 | Itind System |
| Coloplast Corp | $123.17 | 2019-2024 | |
| Antares Pharma, INC. | $99.73 | 2021-2022 | |
| Tolmar, INC. | $88.77 | 2023 | |
| Novartis Pharmaceuticals Corporation | $85.54 | 2024-2025 | |
| Endo USA, INC. | $79.90 | 2025 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $75.43 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $73.48 | 2023-2024 | Yonsa |
| Verity Pharmaceuticals INC. | $71.83 | 2022-2023 | Trelstar |
| Acerus Pharmaceuticals Corporation | $70.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $69.31 | 2023-2024 | Lynparza |
| Convatec INC. | $61.34 | 2019-2022 | |
| 180 Medical, INC. | $60.07 | 2019-2020 | |
| Teleflex LLC | $48.38 | 2022-2024 | Urolift |
| Baxter Healthcare | $40.90 | 2023 | Perclot |
| Medtronic, INC. | $34.78 | 2022 | |
| Calyxo, INC. | $34.72 | 2025 | Cvac Aspiration System |
| Cumberland Pharmaceuticals, INC. | $31.14 | 2023-2024 | Caldolor |
| Rochester Medical Corporation | $24.31 | 2022 | |
| Axonics, INC. | $22.38 | 2024 | Axonics |
| Ambu INC. | $22.21 | 2024 | |
| Immunitybio, INC. | $21.25 | 2025 | |
| Azurity Pharmaceuticals, INC. | $17.00 | 2025 | Azmiro |
| Novo Nordisk INC | $15.22 | 2025 | |
| Dentsply Ih INC. | $14.90 | 2019 | |
| Clarus Therapeutics INC. | $13.93 | 2021 | |
| Laborie Medical Technologies Corp. | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.